Rachael Julia Yuenyinn Tan

Rachael Julia Yuenyinn Tan

Auto-generated profile, based on publicly available information

Rachael Julia Yuenyinn Tan

School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong 1 , Hong Kong

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2024 in Journal of Experimental Medicine
Verified
Journal Article
Open access
JTJia Ming Nickolas Teo
Jia Ming Nickolas Teo
ZCZhulin Chen
Zhulin Chen
WCWeixin Chen
Weixin Chen
RTRachael Julia Yuenyinn Tan
Rachael Julia Yuenyinn Tan
QCQi Cao
Qi Cao
GLGuang Sheng Ling
Guang Sheng Ling
Tumor-associated neutrophils (TANs) are heterogeneous; thus, their roles in tumor development could vary depending on the cancer type. Here, we showed that TANs affect metabolic dysfunction-associated steatohepatitis hepatocellular carcinoma (MASH-related HCC) more than viral-associated HCC. We attributed this difference to the predominance of SiglecFhi TANs in MASH-related HCC tumors. Linoleic acid and GM-CSF, which are commonly elevated in the MASH-related HCC microenvironment, fostered the development of this c-Myc–driven TAN subset. Through TGFβ secretion, SiglecFhi TANs promoted HCC stemness, proliferation, and migration. Importantly, SiglecFhi TANs supported immune evasion by directly suppressing the antigen presentation machinery of tumor cells. SiglecFhi TAN removal increased the immunogenicity of a MASH-related HCC model and sensitized it to immunotherapy. Likewise, a high SiglecFhi TAN signature was associated with poor prognosis and immunotherapy resistance in HCC patients. Overall, our study highlights the importance of understanding TAN heterogeneity in cancer to improve therapeutic development.